| # | Drug | Count |
|---|---|---|
| 0 | ASPIRIN | 6 |
| 1 | ASPIRIN 325 MG | 6 |
| 2 | ASPIRIN 81 MG | 6 |
| 3 | DOXORUBICIN | 6 |
| 4 | IFOSFAMIDE | 6 |
| 5 | IFOSFAMIDE FOR INJECTION | 6 |
| 6 | PREDNISOLONE | 6 |
| 7 | PREDNISOLONE ORAL | 6 |
| 8 | PREDNISOLONE ORAL SOLUTION | 6 |
| 9 | BISOPROLOL FUMARATE | 5 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | HALOBETASOL PROPIONATE AND TAZAROTENE | 1 | 0.0051 |
| 1 | ECONAZOLE NITRATE | 1 | 0.0011 |
| 2 | MESNA INJECTION | 5 | 0.0006 |
| 3 | MESNA | 5 | 0.0006 |
| 4 | RALTEGRAVIR | 3 | 0.0006 |
| 5 | ABACAVIR SULFATE, DOLUTEGRAVIR SODIUM, LAMIVUDINE | 3 | 0.0005 |
| 6 | CISATRACURIUM BESYLATE | 1 | 0.0004 |
| 7 | OXYTOCIN | 1 | 0.0003 |
| 8 | EVEROLIMUS TABLETS | 5 | 0.0003 |
| 9 | ZIDOVUDINE | 3 | 0.0003 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Oxytocic [EPC] | 1 | 0.0003 |
| 1 | Antiseptic [EPC] | 1 | 0.0002 |
| 2 | SARS-CoV-2 Nucleotide Analog RNA Polymerase Inhibitor [EPC] | 1 | 0.0001 |
| 3 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 3 | 0.0001 |
| 4 | Antimetabolite Immunosuppressant [EPC] | 1 | 0.0000 |
| 5 | Provitamin D2 Compound [EPC] | 1 | 0.0000 |
| 6 | Alkylating Drug [EPC] | 8 | 0.0000 |
| 7 | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 3 | 0.0000 |
| 8 | Interleukin-17A Antagonist [EPC] | 1 | 0.0000 |
| 9 | General Anesthetic [EPC] | 1 | 0.0000 |